IEC 60601-1-2 specifies the general requirements and tests for electromagnetic disturbances for medical electrical equipment and medical electrical systems. The fourth edition (2014, with Amendment 1:2020) moved toward a risk-based approach, setting immunity test levels based on the intended use environment: professional healthcare facility, home healthcare or special environments. It covers both emissions (the device should not interfere with others) and immunity (the device should keep working safely when exposed to disturbances such as electrostatic discharge, radio frequency fields and power fluctuations).

Why it matters

EMC test failures are a common late-stage delay. Edition 4.1 introduced more demanding immunity levels for many environments.

Common pitfalls

•Failing to test in the final product configuration, including all accessories and cables, can lead to unexpected EMC issues.
•Underestimating the impact of real-world electromagnetic environments, such as those with portable RF communications equipment, can result in designs that fail immunity tests.
•Delaying EMC testing until late in the development cycle often leads to costly redesigns and project delays.
•Not documenting the electromagnetic compatibility test plan and results thoroughly can lead to regulatory deficiencies during audits.
•Misinterpreting the required immunity test levels for the intended use environment can result in over- or under-testing.

Sources

Open full page

Select term B to compare.

Why compare MedTech terms side by side?

MedTech terminology is full of pairs that look interchangeable but carry very different regulatory, clinical, and commercial consequences. Picking the wrong framework, pathway, or standard early in a project can add months to a submission, invalidate clinical evidence, or trigger an audit finding. Side-by-side comparison is the fastest way to surface those differences before they become costly mistakes.

Each comparison on this page pulls from the same vendor-neutral, sourced definitions used throughout the MedTech Terms glossary. You see the one-line summary, the formal definition, why it matters in practice, common pitfalls, and the primary sources (FDA guidance, EU MDR/IVDR articles, ISO/IEC standards, MDCG documents, IMDRF principles) that back each entry. That makes the comparison defensible in regulatory strategy memos, design reviews, and submission narratives.

Common comparison patterns

Regulatory pathway choice - 510(k) vs PMA, 510(k) vs De Novo, Abbreviated vs Special 510(k).
Quality systems - QSR vs ISO 13485, QMSR vs QSR.
Software classification - SaMD vs SiMD, Locked vs adaptive AI.
EU frameworks - MDR vs IVDR, CE Mark vs UKCA.
Cybersecurity artifacts - SPDX vs CycloneDX SBOM, CVE vs CVSS.
Post-market actions - Recall vs field action, Removal vs correction.

How to use this tool

Pick term A and term B from the dropdowns, or click a preset above. The URL updates with both slugs so you can bookmark or share the exact comparison with a colleague, a notified body reviewer, or your regulatory consultant. Click Open full page on either side for the complete entry, including FAQs, related terms, and the full citation list. If you are not sure which term to start with, browse the Categories view or the A-Z index.

MedTech Terms is a vendor-neutral community resource sponsored by Blue Goat Cyber. Definitions are written for educational use and are not legal or regulatory advice.